twenty-three patients with refractory , aggressive-histology , non-hodgkin 's lymphomas were treated with cytosine arabinoside ( 2.0 g/m2 i.v . every 12 h on days 1 and 2 ) , etoposide ( 100 mg/m2 i.v . on days 1 and 2 ) , and cisplatin ( 35 mg/m2 i.v . on days 1 and 2 ) every 3 weeks .
C0024305
non-hodgkin 's
C0008838
cisplatin